MEGAN RUHNKE: Open Payments
NPI 1366954059 · HARKER HEIGHTS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 41 payments from 11 companies in 2025. Trend: 2023 $594 · 2024 $572 · 2025 $900
Food & beverage: $859Education: $41
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $231 |
| Regeneron Healthcare Solutions, Inc. | 11 | $179 |
| GlaxoSmithKline, LLC. | 8 | $160 |
| CSL Behring | 7 | $142 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Amgen Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| LEO Pharma Inc. | 1 | $16 |
Products named: DUPIXENT, TEZSPIRE, Hizentra, TRELEGY ELLIPTA, FASENRA, NEFFY, AIRSUPRA, NUCALA.
Industry payments across TX — which companies pay providers there.
